4 completed, 2 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 4, Terminated 2 |
Follow Exubera: new trials by email Literature Review of Exubera trials Research Report on Exubera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera. Inhaled Human Insulin (Exubera) - Diabetes Mellitus, Type 2 | Phase 4 | Terminated | Pfizer | 49 | 2007-06-01 | 2009-05-11 |
| This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus Insulin glargine, Inhaled Insulin (Exubera) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer | 413 | 2007-03-01 | 2026-08-11 |
| A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® Insulin Glargine (Lantus®), Inhaled Human Insulin (Exubera®) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer | 261 | 2006-12-01 | 2026-08-11 |
| A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog® Inhaled Human Insulin (Exubera®), Insulin lispro (Humalog) - Diabetes Mellitus, Type 1 | Phase 4 | Terminated | Pfizer | 58 | 2006-11-01 | 2009-09-02 |
| A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus Inhaled Human Insulin (Exubera), Insulin Glargine (Lantus) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer | 30 | 2006-09-01 | 2008-01-29 |
| Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes Exubera - Type 1 Diabetes Mellitus | Phase 4 | Completed | University of Pittsburgh | 12 | 2006-04-01 | 2008-02-18 |
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus, Type 1 (2) · Insulin Resistance (1)
Pfizer (5) · University of Pittsburgh (1)
United States (4) · Belgium (2) · Finland (2) · France (2) · Netherlands (2) · Norway (2) · Spain (2) · Sweden (2) · Austria (1) · Denmark (1) · Germany (1) · Hong Kong (1) · Ireland (1) · Pakistan (1) · Philippines (1)